Details for New Drug Application (NDA): 018891

✉ Email this page to a colleague

NDA 018891 describes CATAPRES-TTS-3, which is a drug marketed by Lavipharm and is included in one NDA. It is available from two suppliers. Additional details are available on the CATAPRES-TTS-3 profile page.

The generic ingredient in CATAPRES-TTS-3 is clonidine. There are twenty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the clonidine profile page.

Summary for 018891

Tradename:	CATAPRES-TTS-3
Applicant:	Lavipharm
Ingredient:	clonidine
Patents:	0

Pharmacology for NDA: 018891

Mechanism of Action	Adrenergic alpha2-Agonists

Medical Subject Heading (MeSH) Categories for 018891

Adrenergic alpha-2 Receptor Agonists
Analgesics
Antihypertensive Agents
Sympatholytics

Suppliers and Packaging for NDA: 018891

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CATAPRES-TTS-1	clonidine	SYSTEM;TRANSDERMAL	018891	NDA AUTHORIZED GENERIC	TruPharma, LLC	52817-610	52817-610-04	4 POUCH in 1 CARTON (52817-610-04) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH
CATAPRES-TTS-1	clonidine	SYSTEM;TRANSDERMAL	018891	NDA AUTHORIZED GENERIC	TruPharma, LLC	52817-611	52817-611-04	4 POUCH in 1 CARTON (52817-611-04) / 1 PATCH in 1 POUCH / 1 d in 1 PATCH

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	SYSTEM;TRANSDERMAL			Strength	0.1MG/24HR
Approval Date:	Oct 10, 1984	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	SYSTEM;TRANSDERMAL			Strength	0.2MG/24HR
Approval Date:	Oct 10, 1984	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	SYSTEM;TRANSDERMAL			Strength	0.3MG/24HR
Approval Date:	Oct 10, 1984	TE:	AB	RLD:	Yes

Expired US Patents for NDA 018891

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Lavipharm	CATAPRES-TTS-2	clonidine	SYSTEM;TRANSDERMAL	018891-002	Oct 10, 1984	4,559,222	⤷ Get Started Free
Lavipharm	CATAPRES-TTS-3	clonidine	SYSTEM;TRANSDERMAL	018891-003	Oct 10, 1984	4,201,211	⤷ Get Started Free
Lavipharm	CATAPRES-TTS-1	clonidine	SYSTEM;TRANSDERMAL	018891-001	Oct 10, 1984	4,559,222	⤷ Get Started Free
Lavipharm	CATAPRES-TTS-2	clonidine	SYSTEM;TRANSDERMAL	018891-002	Oct 10, 1984	4,201,211	⤷ Get Started Free
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.